Fundraising Fox
Wavegate
Lake Charles, US · Founded 2025 · Delaware corporation
Find your way into Wavegate
Sign up to see every warm intro you have to Wavegate
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Wavegate team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Wavegate develops the Ellipse™ platform, an implantable bioadaptive electroceutical system that combines multi-modal physiologic sensing (optical reflectometry, evoked potentials, hemodynamics, ECG, and motion) with AI-based state estimation and adaptive control to deliver closed-loop neuromodulation therapy, starting with spinal cord stimulation for chronic pain. The company targets clinicians and researchers in neuromodulation, with all programs currently investigational and not FDA-approved.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$5.2M disclosed across 2 rounds · 2020–2025
▶$2.8MraisedJun 2025 · 38 investors · Other Health CareRule 506(b)
- Erich Wolf, IIExecutive Officer, Director
- Matthew ThomasDirector
- Ashley WadeDirector
- D. Patrick O'NealDirector
- Marla A. MillerExecutive Officer
- Offering amount
- $28.7M
- Amount sold
- $2.8M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
▶$2.4MraisedMar 2023 · 38 investors · Other Health CareRule 506(b)
- Ashley WadeDirector
- Marla A MillerExecutive Officer
- Russell J. Stutes, Jr.Executive Officer
- Robert E EhlersExecutive Officer
- Dennis Patrick O'NealDirector
- Erich William Wolf, IIExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $2.4M
- Minimum investment
- $25K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Wavegate.
In the news
Frequently asked questions
- What does Wavegate do?
- Wavegate develops the Ellipse™ platform, an implantable bioadaptive electroceutical system that combines multi-modal physiologic sensing (optical reflectometry, evoked potentials, hemodynamics, ECG, and motion) with AI-based state estimation and adaptive control to deliver closed-loop neuromodulation therapy, starting with spinal cord stimulation for chronic pain. The company targets clinicians and researchers in neuromodulation, with all programs currently investigational and not FDA-approved.
- How much funding has Wavegate raised?
- Wavegate has disclosed $5.2M raised across 2 rounds.
- Where is Wavegate headquartered?
- Wavegate is headquartered in Lake Charles, US.